951745-01-0

Basic information

• Product Name: N-Boc-4-MethylpiperidinecarbothioaMide
• Synonyms: N-Boc-4-MethylpiperidinecarbothioaMide;4-Methyl-4-thiocarbaMoylpiperidine-1-carboxylic acid tert-butyl ester
• CAS NO: 951745-01-0
• Molecular Formula: C₁₂H₂₂N₂O₂S
• Molecular Weight: 258
• Mol File: 951745-01-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-Boc-4-MethylpiperidinecarbothioaMide(CAS DataBase Reference)
• NIST Chemistry Reference: N-Boc-4-MethylpiperidinecarbothioaMide(951745-01-0)
• EPA Substance Registry System: N-Boc-4-MethylpiperidinecarbothioaMide(951745-01-0)

Safety Data

• Hazardous Substances Data: 951745-01-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
N-Boc-4-Methylpiperidinecarbothioamide is used as a reagent for the synthesis of pharmaceutical drugs. Its versatile nature in chemical reactions allows for the creation of a wide range of bioactive compounds, making it a valuable asset in drug development.
Used in Agrochemical Production:
N-Boc-4-Methylpiperidinecarbothioamide is also utilized in the production of agrochemicals. Its role as a building block in the synthesis of various compounds contributes to the development of effective agricultural products.
Used in Organic Synthesis:
As a reagent in organic synthesis, N-Boc-4-Methylpiperidinecarbothioamide is employed for the creation of a diverse array of chemical compounds. Its versatility in chemical reactions makes it a valuable component in the synthesis process.

Upstream product

• 530115-96-9 4-cyano-4-methylpiperidine-1-carboxylic acid tert-butyl ester 
• 91419-52-2 1-tert-butoxycarbonyl-4-cyanopiperidine 
• 343788-67-0 4-carbamoyl-4-methylpiperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 1037792-97-4 4-[4-(4-methanesulfonylphenoxymethyl)thiazol-2-yl]-4-methylpiperidine-1-carboxylic acid tert-butyl ester 
• 1195769-66-4 1,1-dimethylethyl 4-[5-(2-amino-4-pyrimidinyl)-4-(3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorophenyl)-1,3-thiazol-2-yl]-4-methyl-1-piperidinecarboxylate 
• 1195769-64-2 1,1-dimethylethyl 4-[5-(2-chloro-4-pyrimidinyl)-4-(3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorophenyl)-1,3-thiazol-2-yl]-4-methyl-1-piperidinecarboxylate 
• 1195769-67-5 1,1-dimethylethyl 4-(5-(2-chloro-4-pyrimidinyl)-4-{2-fluoro-3-[(3-furanylsulfonyl)amino]phenyl}-1,3-thiazol-2-yl)-4-methyl-1-piperidinecarboxylate 
• 1195769-68-6 1,1-dimethylethyl 4-(5-(2-amino-4-pyrimidinyl)-4-{2-fluoro-3-[(3-furanylsulfonyl)amino]phenyl}-1,3-thiazol-2-yl)-4-methyl-1-piperidinecarboxylate 
• 1195768-01-4 N-{3-[5-(2-amino-4-pyrimidinyl)-2-(4-methyl-4-piperidinyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-3-furansulfonamide 
• 1307271-96-0 1,1-dimethylethyl 4-(4-{2-fluoro-3-[(propylsulfonyl)amino]phenyl}-5-{2-[(2-hydroxyethyl)amino]-4-pyrimidinyl}-1,3-thiazol-2-yl)-4-methyl-1-piperidinecarboxylate 
• 1307271-95-9 N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1,4-dimethyl-4-piperidinyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-1-propanesulfonamide trifluoroacetate 
• 1307271-93-7 N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(4-methyl-4-piperidinyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-1-propanesulfonamide 
• 1307271-92-6 1,1-dimethylethyl 4-(5-(2-amino-4-pyrimidinyl)-4-{2-fluoro-3-[(propylsulfonyl)amino]phenyl}-1,3-thiazol-2-yl)-4-methyl-1-piperidinecarboxylate 
• 1307271-91-5 1,1-dimethylethyl 4-(5-(2-chloro-4-pyrimidinyl)-4-{2-fluoro-3-[(propylsulfonyl)amino]phenyl}-1,3-thiazol-2-yl)-4-methyl-1-piperidinecarboxylate 
• 1307271-89-1 N-{3-[5-(2-amino-4-pyrimidinyl)-2-(4-methyl-4-piperidinyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-1-propanesulfonamide 
• 1307271-30-2 N-{2-fluoro-3-[5-{2-[(2-hydroxyethyl)amino]-4-pyrimidinyl}-2-(4-methyl-4-piperidinyl)-1,3-thiazol-4-yl]phenyl}-1-propanesulfonamide 
• 1307271-29-9 N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,4-dimethyl-4-piperidinyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-1-propanesulfonamide hydrochloride 

Relevant articles and documents

OXYMETHYLENE ARYL COMPOUNDS FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES OR GASTROINTESTINAL CONDITIONS

Use of oxymethylene aryl GPRl 19 agonists, and optionally DPP IV inhibitors and optionally metformin, for the treatment of inflammatory gastrointestinal diseases or gastrointestinal conditions involving malabsorption of nutrients and/or fluids are provide

UREIDE DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES

This invention relates to a pharmaceutical comprising, as an active ingredient, a ureide derivative represented by formula: or a pharmaceutically acceptable salt thereof. The ureide derivative or a pharmaceutically acceptable salt thereof according to the present invention is useful for relieving pain and treating or preventing neuropathic pain.

HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF DIABETES AND METABOLIC DISORDERS

Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.